GLP-1 medications are usually prescribed for people with type 2 diabetes or those with a higher body weight where other methods have not been successful
Starting at low doses allows your body to tolerate the medication while your appetite center gradually adapts, preventing the intense nausea and gastrointestinal side effects that sometimes occur with rapid dose advancement
Compounded semaglutide and tirzepatide products are not the same as FDA-approved brand-name medications
If youre currently receiving treatment elsewhere or have recently done so, make sure to include your current or most recent dose on your intake form so your provider can factor that in from day one
You can also ice if desired
In our study, we examine: Trends in GLP-1 prevalence, adherence data, and potential obstacles to continued use Impacts on mortality among individuals taking these drugs Implications for assessing metabolic risk and the crucial role electronic health records (EHRs) will play Key results GLP-1s may drive 0.2%0.5% annual mortality improvement, realized over a 20-year period